Evidence map›Paper›PMID 40975454›Full record

ArticleMatrix biology : journal of the International Society for Matrix Biology2025

Extracellular matrix architecture promotes immunosuppressive microenvironments in pancreatic cancer.

Mackenzie K Callaway, Brock J Noonan, Kathryn L Schwertfeger, Paolo P Provenzano

Abstract read
In one paragraph

Article in Matrix biology : journal of the International Society for Matrix Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mackenzie K CallawayDepartment of Biomedical Engineering, University of Minnesota, USA.
Brock J NoonanDepartment of Biomedical Engineering, University of Minnesota, USA.
Kathryn L SchwertfegerDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis 55455, USA; Masonic Cancer Center, University of Minnesota, USA.
Paolo P ProvenzanoDepartment of Biomedical Engineering, University of Minnesota, USA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis 55455, USA; University of Minnesota Center for Multiparametric Imaging of Tumor Immune Microenvironments, USA; Department of Hematology, Oncology, and Transplantation, University of Minnesota, USA. Electronic address: pprovenz@umn.edu.

Funding

Project 2: Cell Migration in Mechanically Complex MicroenvironmentsU54CA210190 · NCI · UNIVERSITY OF MINNESOTA · PI LARGAESPADA, DAVID ANDREW, ODDE, DAVID J. · 2016 to 2020
$10.0M
Project 3P01CA254849 · NCI · UNIVERSITY OF MINNESOTA · PI LARGAESPADA, DAVID ANDREW, MASOPUST, DAVID · 2021 to 2025
$9.4M
TECH CoreU54CA268069 · NCI · UNIVERSITY OF MINNESOTA · PI David J. Odde · 2022 to 2026
$8.2M
Stomal Senescence Regulator of Tumor Immunity and ProgressionR01CA286615 · NCI · WASHINGTON UNIVERSITY · PI David G DeNardo, Paolo Provenzano · 2024 to 2026
$3.2M
A platform to functionally sort and analyze tumor cells within combinatorial metastatic micorenvironmentsR01CA245550 · NCI · UNIVERSITY OF MINNESOTA · PI PROVENZANO, PAOLO, WOOD, DAVID KEVIN · 2020 to 2024
$2.9M
NCI NIH HHS P01 CA254849NCI NIH HHS R01 CA245550NCI NIH HHS R01 CA286615NCI NIH HHS U54 CA210190NCI NIH HHS U54 CA268069NSF Fellowship 1839286
6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDA) is an aggressive cancer with poor clinical outcomes, due in part to altered fibrotic environments and striking immune dysfunction. Physical properties within tumors, such as aligned extracellular matrix (ECM) fiber architectures, are fundamental to cancer progression and outcome. However, the influence of ECM alignment on immune cell localization and function within tumors, particularly PDA, remains largely unexplored. Here, analysis of mouse and human PDA reveal an inextricable link between collagen architecture and the distribution of immunosuppressive macrophages in both early preinvasive disease and invasive carcinomas. In vitro characterization of primary macrophages demonstrates alignment alone is sufficient to induce elongation, polarization, and immunosuppressive activity, including suppression of CD8+ T cell proliferation and motility. Analysis reveals differential focal adhesion kinase (FAK) activity in aligned macrophages, while FAK inhibition (FAKi) disrupts the immunosuppressive phenotype that emerges from encountering ECM alignment. Furthermore, FAKi in vivo significantly reduces the correlation between elongated immunosuppressive macrophages and aligned collagen, further highlighting the opportunity for FAKi to target stromal immunity. Importantly, the correlation between aligned collagen and immunosuppressive macrophages is also observed in human chronic pancreatitis, a known PDA risk factor that has recently been shown to prime stromal ECM alignments for early dissemination, suggesting that precursor disease is also likely to create stromal memory conducive to early immunosuppression. Taken together, these results support a model in which collagen architecture supports early establishment and maintenance of an immunosuppressive microenvironments and defines a role for targeting stromal matrices to "reprogram" patient immunity.

Indexed as

Carcinoma, Pancreatic DuctalExtracellular MatrixPancreatic NeoplasmsTumor MicroenvironmentAnimalsCell AdhesionCell LineCell ProliferationCollagenFemaleFocal Adhesion Protein-Tyrosine KinasesHumansMacrophagesMaleMiceMice, Inbred C57BLCollagenFocal Adhesion Protein-Tyrosine KinasesContact guidanceImmunosuppressionMacrophage polarizationTumor microenvironment

Identifiers

PMID40975454
PMCPMC12536408

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.